Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_assertion type Assertion NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_head.
- NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_assertion description "[In contrast, KRAS mutations were identified only in adenocarcinomas (17.5% vs 0%; P = .01), and a novel EGFR mutation was detected only in squamous cell carcinomas (0% vs 7.5%; P = .24).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_provenance.
- NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_assertion evidence source_evidence_literature NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_provenance.
- NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_assertion SIO_000772 24037752 NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_provenance.
- NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_assertion wasDerivedFrom befree-2016 NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_provenance.
- NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_assertion wasGeneratedBy ECO_0000203 NP1110716.RApi-8eppbPxmHDyckMXIGuAVefS8gdfHJG5A5dQTwTO8130_provenance.